Envestnet Asset Management
AUPH icon

Envestnet Asset Management’s Aurinia Pharmaceuticals AUPH Stock Holding History

Envestnet Asset Management’s Portfolio AUPH Stock Details AUPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-25,838
Closed -$194K – 3950
2022
Q3 		$194K Sell
25,838
-3,390
-12% -$29.3K ﹤0.01% 3594
2022
Q2 		$294K Buy
29,228
+411
+1% +$4.59K ﹤0.01% 3367
2022
Q1 		$357K Sell
28,817
-5,104
-15% -$78.9K ﹤0.01% 3345
2021
Q4 		$776K Sell
33,921
-3,605
-10% -$85.4K ﹤0.01% 2795
2021
Q3 		$830K Sell
37,526
-10,774
-22% -$171K ﹤0.01% 2661
2021
Q2 		$626K Buy
48,300
+5,092
+12% +$64.9K ﹤0.01% 2832
2021
Q1 		$561K Buy
+43,208
New +$627K ﹤0.01% 2776

Other funds holding AUPH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return